首页> 外文OA文献 >Outcomes in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with isolated deletion 5q treated with lenalidomide: a subset analysis from the MDS-004 study

【2h】

Outcomes in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with isolated deletion 5q treated with lenalidomide: a subset analysis from the MDS-004 study

机译：RBC输血依赖患者的结果：低剂量/中度-1风险的骨髓增生异常综合征与来那度胺治疗的孤立性缺失5q：来自mDs-004研究的亚组分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Giagounidis, Aristoteles; Mufti, Ghulam J.; Mittelman, Moshe; Sanz, Guillermo; Platzbecker, Uwe; Muus, Petra; Selleslag, Dominik; Beyne-Rauzy, Odile; te Boekhorst, Peter; del Canizo, Consuelo; Guerci-Bresler, Agnes; Nilsson, Lars; Luebbert, Michael; Quesnel, Bruno; Ganser, Arnold; Bowen, David; Schlegelberger, Brigitte; Goehring, Gudrun; Fu, Tommy; Benettaib, Bouchra; Hellstrom-Lindberg, Eva; Fenaux, Pierre;
展开▼
作者单位

展开▼
年度 2014
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献

1. Health-related quality of life outcomes of lenalidomide in transfusion-dependent patients with Low- or Intermediate-1-risk myelodysplastic syndromes with a chromosome 5q deletion: Results from a randomized clinical trial [J] . RevickiD.A., BrandenburgN.A., MuusP., Leukemia Research: A Forum for Studies on Leukemia and Normal Hemopoiesis . 2013,第3期

机译：来那度胺在依赖输血的低风险或中度1风险性骨髓增生异常综合征伴有染色体5q缺失的患者中与健康有关的生活质量结果：一项随机临床试验的结果
2. Lenalidomide: A review of its use in patients with transfusion-dependent anaemia due to low- or intermediate-1-risk myelodysplastic syndrome associated with 5q chromosome deletion [J] . SyedY.Y., ScottL.J. Drugs: International Journal of Current Therapeutics and Applied Pharmacology Reviews, Featuring Evaluations on New Drugs, Review Articles on Drugs and Drug Therapy, and Drug Literature Abstracts . 2013,第11期

机译：来那度胺：综述其在低危或中度1风险性骨髓增生异常综合症与5q染色体缺失相关的输血依赖性贫血患者中的应用
3. A randomized phase 3 study of lenalidomide versus placebo in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with del5q. [J] . Fenaux P, Giagounidis A, Selleslag D, Blood: The Journal of the American Society of Hematology . 2011,第14期

机译：来那度胺与安慰剂在RBC输血依赖性低/中1风险性骨髓增生异常综合征del5q的患者中的3期随机研究。
4. Chronic Bone Marrow Failure and Transfusion Patterns: Epidemiological Studies of Blood Transfusions and Outcomes in Patients with Myelodysplastic Syndromes [D] . Rydén, Jenny. 2021

机译：慢性骨髓衰竭和输血模式：骨髓增生综合征患者出血和结果的流行病学研究
5. Outcomes in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with isolated deletion 5q treated with lenalidomide: a subset analysis from the MDS-004 study [O] . Aristoteles Giagounidis, Ghulam J Mufti, Moshe Mittelman, -1

机译：来那度胺治疗的独立缺失5q的低/中度1风险骨髓增生异常综合征的RBC输血依赖性患者的结果：MDS-004研究的子集分析
6. Outcomes in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with isolated deletion 5q treated with lenalidomide: A subset analysis from the MDS-004 study [O] . Giagounidis, Aristoteles, Mufti, Ghulam, Mittelman, Moshe, 2014

机译：来那度胺治疗的独立缺失5q的低/中度-1风险性骨髓增生异常综合症的RBC输血依赖性患者的结果：MDS-004研究的子集分析

Outcomes in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with isolated deletion 5q treated with lenalidomide: a subset analysis from the MDS-004 study

著录项

相似文献

相关主题

期刊订阅